Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Recruiting 19Completed 9Active not recruiting 8Withdrawn 2Terminated 2Not yet recruiting 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Neoplasm, Residual 2Leukemia 2Burkitt Lymphoma 2Myasthenia Gravis 1Leukemia, Myeloid 1Leukemia, Lymphoid 1Graft vs Host Disease 1

Interventions

blinatumomab 2Immunotherapy, Adoptive 2pomalidomide 1Specimen Handling 1Interleukin 1 Receptor Antagonist Protein 1Inotuzumab Ozogamicin 1Biological Products 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Burkitt Lymphoma × blinatumomab × Clear all
NCT07313852 2026-04-20

A Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic Leukemia

Memorial Sloan Kettering Cancer Center

Phase 1/2 Not yet recruiting
26 enrolled
Lymphoid

Burkitt Lymphoma

NCT07476729 2026-03-17

International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)

Charite University, Berlin, Germany

Phase 3 Not yet recruiting
750 enrolled
Lymphoid

Burkitt Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡